Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes

Angela Vidal-Jordana, Jaume Sastre-Garriga, Francisco Pérez-Miralles, Carmen Tur, Mar Tintoré, Alejandro Horga, Cristina Auger, Jordi Río, Carlos Nos, Mari C. Edo, María J. Arévalo, Joaquín Castilló, Alex Rovira, Xavier Montalban

Research output: Contribution to journalArticleResearchpeer-review

67 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes'. Together they form a unique fingerprint.

Medicine & Life Sciences